from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2140c/TB18.6

LFCtreatmentdescriptionclass of inhibitor

-0.185

Amikacinug/mL Amikacintranslation

0.085

Cap5-10ug/mL Capreomycintranslation

-0.305

Rox10-50 ug/mL Roxithromycintranslation

-0.300

SM2-5 ug/mL Streptomycintranslation

1.229

Tet5-10 ug/mL Tetracyclinetranslation

0.190

Rif0.2-5ug/mL Rifampicintranscription

0.113

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.032

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.878

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.298

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.620

Clofazimine10-13 ug/mL Clofaziminerespiration

0.721

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.219

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.267

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.308

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.556

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.476

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.883

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.785

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.067

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.264

KCN5-20 ug/mL Potassium cyaniderespiration

-0.509

NaN30.2-2 mM Sodium aziderespiration

1.042

Nigericin50 uM Nigericinrespiration

0.005

TRC10-150 ug/mL Triclosanrespiration

-1.406

TRZ10-25 ug/mL Thioridazinerespiration

-0.758

Valinomycin0.5-10 uM Valinomycinrespiration

1.214

ZnSO42 mM ZnSO4respiration

-0.191

menadione6-10 ug/mL Menadionerespiration

0.143

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.642

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.363

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.834

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.148

NRP_1Non-replicating persistence stage 1dosRassociated

0.338

Amp0.2mg/mL AmpicillincellWall

0.316

Cephalexin20-100 ug/mL CephalexincellWall

0.774

Cerulenin0.32-5 ug/mL CerulenincellWall

0.780

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.207

EMB10-20 ug/mL EthambutolcellWall

0.391

Eta12-40 ug/mL EthionamidecellWall

0.326

INH0.2-0.4 ug/mL IsoniazidcellWall

0.600

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.979

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.013

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.961

BZA0.12 mg/mL BenzamidearomaticAmides

0.072

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.408

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.278

H2O24 mM hydrogen peroxideDNAdamaging

0.252

Levo10 ug/mL LevofloxacinDNAdamaging

0.749

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-2.825

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.344

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.587

UVUV-irradiationDNAdamaging

-0.456

ARP41-4 ug/mL Antitubercular compound ARP4?

1.041

Antimycin12.5-50 ug/mL Antimycin A?

0.704

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.657

PA_110-50 ug/mL Antitubercular compound PA-1?

1.054

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.745

PA8240.2-2 ug/mL PA-824?

-2.117

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.418

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.155

Verapamil50 uM Verapamil?

0.793

mercaptoethanol2 mM 2-Mercaptoethanol?

0.625

methoxatin10-20 ug/mL Methoxatin?